Provided by Tiger Trade Technology Pte. Ltd.

Kyndryl

13.40
+0.19501.48%
Volume:1.36M
Turnover:17.99M
Market Cap:2.92B
PE:36.20
High:13.40
Open:13.06
Low:12.89
Close:13.20
52wk High:33.90
52wk Low:10.10
Shares:217.82M
Float Shares:199.00M
Volume Ratio:0.88
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3700
EPS(LYR):0.8500
ROE:6.93%
ROA:3.02%
PB:2.73
PE(LYR):15.76

Loading ...

FalconStor Q2 Revenue Rises, Net Loss Narrows on Hybrid Cloud Offerings, Operational Streamlining, Respectively

Reuters
·
Aug 06

TaskUs Q2 Revenue Beats Estimates, Raises 2026 Revenue View

Reuters
·
Aug 06

Kyndryl Shares Down 3.7% After Co Misses Q1 Revenue Estimates

THOMSON REUTERS
·
Aug 06

Kyndryl Holdings, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Kyndryl Misses Quarterly Estimates on Weak Sales and Charges Linked to Job Cuts

Reuters
·
Aug 05

Kyndryl Holdings reports Q1 adjusted EPS (12c), consensus (12c)

TIPRANKS
·
Aug 05

Kyndryl Holdings Q1 EPS USD -0.25

Reuters
·
Aug 05

Kyndryl FY27 Q1 Swings to Net Loss of $55 Million; Revenue Falls 3% to $3.6 Billion

Reuters
·
Aug 05

Kyndryl Q1 Revenue Misses Estimates on Weak Segment Performance

Reuters
·
Aug 05

Kyndryl Fiscal Q1 2027 Earnings: Workforce Charges Weigh on Profitability

TradingKey
·
Aug 05

Kyndryl Hldgs Q1 Adj. EPS $(0.12) Misses $(0.07) Estimate, Sales $3.618B Miss $3.661B Estimate

Benzinga Earnings
·
Aug 05

Kyndryl Holdings Q1 Adjusted EPS USD -0.12

THOMSON REUTERS
·
Aug 05

Kyndryl Holdings - Incurs $152 Mln Workforce Rebalancing Charges in Q1

THOMSON REUTERS
·
Aug 05

Kyndryl Holdings - Expects $200 Mln Workforce Rebalancing Charges in Fy2027, $400-$500 Mln Savings in Fy2028

THOMSON REUTERS
·
Aug 05

Kyndryl Holdings, - Reaffirms Fiscal 2027 Outlook for Revenue, Earnings and Free Cash Flow

THOMSON REUTERS
·
Aug 05

Kyndryl Holdings Q1 Revenue USD 3,618 Million VS. Ibes Estimate USD 3,639 Million

THOMSON REUTERS
·
Aug 05

Kyndryl Reports First Quarter Fiscal 2027 Results

THOMSON REUTERS
·
Aug 05

Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation

GlobeNewswire
·
Aug 03

Super Micro Computer Stock And 2 AI Software Plays Worth A Closer Look

Simply Wall St.
·
Aug 01

Kyndryl Shareholders Approve Governance and Compensation Measures

TIPRANKS
·
Aug 01